FDA To Lower Risk Category For Hemodialysis Devices
The U.S. Food and Drug Administration released draft guidance Wednesday to lower the risk category associated with implanted blood access devices used for hemodialysis and provided additional instructions for manufacturers to...To view the full article, register now.
Already a subscriber? Click here to view full article